Cargando…
Cellular Cardiomyoplasty and Cardiac Regeneration
Despite of vast improvements in treatment, myocardial infarction often leads to heart failure (HF) which remains the leading cause of death in developed countries. Other than heart transplantation, therapeutic options have a limited role in improving out comes in patients with severe HF. It is there...
Autores principales: | Pendyala, Lakshmana, Goodchild, Traci, Gadesam, Radhika R., Chen, Jack, Robinson, Keith, Chronos, Nicolas, Hou, Dongming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779354/ https://www.ncbi.nlm.nih.gov/pubmed/19936280 http://dx.doi.org/10.2174/157340308784245748 |
Ejemplares similares
-
Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure
por: Taylor, Doris A
Publicado: (2001) -
New Approaches in Heart Research: Prevention Instead of Cardiomyoplasty?
por: Gaebel, Ralf, et al.
Publicado: (2023) -
NF-E2-related factor 2 over-expression in mesenchymal stem cells to improve cellular cardiomyoplasty
por: Mohammadzadeh-Vardin, Mohammad, et al.
Publicado: (2014) -
Ghrelin and Cardiovascular Diseases
por: Zhang, Gaigai, et al.
Publicado: (2010) -
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease
por: Williams, Paul, et al.
Publicado: (2011)